Aquinox Pharmaceuticals Reaches New 52-Week Low at $6.31 (AQXP)
Aquinox Pharmaceuticals (NASDAQ:AQXP) hit a new 52-week low during mid-day trading on Friday , American Banking News reports. The company traded as low as $6.31 and last traded at $6.44, with a volume of 27,181 shares. The stock had previously closed at $6.54.
Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Aquinox Pharmaceuticals in a research note on Tuesday, August 12th. They now have a $16.00 price target on the stock, down previously from $17.00.
The stock’s 50-day moving average is $7.89 and its 200-day moving average is $9.57. The company’s market cap is $68.7 million.
Aquinox Pharmaceuticals (NASDAQ:AQXP) last released its earnings data on Monday, August 11th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by $0.24. Analysts expect that Aquinox Pharmaceuticals will post $-1.33 EPS for the current fiscal year.
Aquinox Pharmaceuticals, Inc is a clinical-stage pharmaceutical company discovering and developing drug candidates to treat inflammation and cancer.
Receive News & Ratings for Aquinox Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aquinox Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.